MBL-low patients showed a cytokine profile after stroke characterized by a greater increase of IL-10, a lower rise of IL-6, and no significant changes of TNF-α compared to patients with MBL-sufficient genotypes (Fig. 6A–D). The gene discussed is MBL2; the disease is stroke disorder.